<img alt="" height="1" width="1" />AMRI Advances New Irritable Bowel Syndrome Treatment Toward IND SubmissionMarketWatch (press release)AMRI's 5-HT3 partial agonist represents a novel approach to the treatment of IBS, a disease-complex for which there are few currently available therapies ...<nobr>and more »</nobr> |